PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-233.51%
Both yoy net incomes decline, with BTE at -64.30%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
370.00%
Some yoy growth while BTE is negative at -58.64%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
46.67%
SBC growth while BTE is negative at -43.90%. John Neff would see competitor possibly controlling share issuance more tightly.
-161.00%
Negative yoy working capital usage while BTE is 1495.33%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-161.00%
Negative yoy usage while BTE is 815.37%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-10.81%
Negative yoy while BTE is 31.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-50.59%
Both yoy CFO lines are negative, with BTE at -12.34%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-11.86%
Negative yoy CapEx while BTE is 27.41%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
41.18%
Less M&A spending yoy vs. BTE's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
11.86%
Purchases growth of 11.86% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
16.07%
Liquidation growth of 16.07% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-10.17%
We reduce yoy other investing while BTE is 139.50%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-6.51%
We reduce yoy invests while BTE stands at 46.01%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.